Performing percutaneous coronary intervention (PCI) significantly improved outcomes in patients with stable coronary artery disease (CAD) and severe aortic stenosis selected for transcatheter aortic ...

The interest in dual antiplatelet therapy after valve-in-valve transcatheter aortic valve intervention stems from the higher thrombotic risk associated with reintervention for a bioprosthetic valve ...

Earlier intervention in severe asymptomatic valve disease, age recommendations to help guide the choice of TAVI versus SAVR, and an upward nudge for transcatheter edge-to-edge repair (TEER) for ...

While it’s possible to protect the coronary ostia, sometimes with a stent and sometimes with leaflet modification, it might be in patients’ best interest if the heart team goes with surgical aortic ...

The randomized PRO-TAVI trial showed that in patients with coronary artery disease undergoing transcatheter aortic valve ...

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were ...

As reported by heartwire, Dr Craig Miller (Stanford University, CA) presented new details on the neurological-event data from PARTNER cohort A, which included high-risk patients eligible for either ...